Author： Tan Ricardo A Corren Jonathan
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.10, Iss.3, 2011-05, pp. : 463-471
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Omalizumab attacks paediatric asthma
Inpharma, Vol. 1, Iss. 1659, 2008-01 ,pp. :
Access to resources
Recommend
FDA is reviewing safety of omalizumab
Reactions Weekly, Vol. 1, Iss. 1262, 2009-01 ,pp. :
NICE no longer recommends omalizumab for asthma . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 667, 2012-01 ,pp. :
Omalizumab effective in allergic asthma and allergic rhinitis
Inpharma, Vol. 1, Iss. 1408, 2003-01 ,pp. :
Omalizumab - systemic asthma and rhinitis therapy in the new millennium
Inpharma, Vol. 1, Iss. 1284, 2001-01 ,pp. :